Imbria Pharmaceuticals to Participate in Select Fall Healthcare Conferences
September 15, 2026 Imbria Pharmaceuticals to Participate in Select Fall Healthcare Conferences Executive leadership to participate in upcoming investor and industry events to highlight Imbria’s differentiated approach to cardiac energetics and clinical development strategy BOSTON, Mass., September 15, 2026 — Imbria Pharmaceuticals, Inc. (Imbria), a clinical-stage company developing innovative therapeutics for cardiovascular diseases, today […]
Imbria Pharmaceuticals to Participate in Select Fall Healthcare Conferences Read More »